

























700Vascular Quality of Life Questionnaire-6 facilitates
health-related quality of life assessment in peripheral
arterial disease
Joakim Nordanstig, MD,a Christine Wann-Hansson, PhD,b Jan Karlsson, PhD,c,d
Mats Lundström, MD, PhD,e Monica Pettersson, PhD,a,d and Mark B. F. Morgan, FRCS,f
Gothenburg, Malmö, Örebro, and Lund, Sweden; and Tauranga, New Zealand
Background: Most commonly used outcome measures in peripheral arterial disease (PAD) provide scarce information
about achieved patient beneﬁt. Therefore, patient-reported outcome measures have become increasingly important as
complementary outcome measures. The abundance of items in most health-related quality of life instruments makes
everyday clinical use difﬁcult. This study aimed to develop a short version of the 25-item Vascular Quality of Life
Questionnaire (VascuQoL-25), a PAD-speciﬁc health-related quality of life instrument.
Methods: The study recruited 129 individuals with intermittent claudication and 71 with critical limb ischemia from two
university hospitals. Participants were a mean age of 70 6 9 years, and 57% were men. All patients completed the original
VascuQoL when evaluated for treatment, and 127 also completed the questionnaire 6 months after a vascular procedure.
The VascuQoL-25 was reduced based on cognitive interviews and psychometric testing. The short instrument, the
VascuQoL-6, was tested using item-response theory, exploring structure, precision, item ﬁt, and targeting. A subgroup of
21 individuals with intermittent claudication was also tested correlating the results of VascuQoL-6 to the actual walking
capacity, as measured using global positioning system technology.
Results: On the basis of structured psychometric testing, the six most informative items were selected (VascuQoL-6) and
tested vs the original VascuQoL-25. The correlation between VascuQoL-25 and VascuQoL-6 was r [ 0.88 before
intervention, r[ 0.96 after intervention, and the difference was r[ 0.91 (P < .001). The Cronbach a for the VascuQoL-
6 was .85 before and .94 after intervention. Cognitive interviews indicated that the responders considered all six items to
be relevant and comprehensible. Rasch analysis was used to reduce response options from seven (VascuQoL-25) to four
(VascuQoL-6). VascuQol-6 was shown to have high precision and discriminative properties. Item ﬁt was excellent, with
both “inﬁt” and “outﬁt” between 0.7 and 1.3 for all six items. The standardized response mean after intervention was
1.15, indicating good responsiveness to clinical change. VascuQoL-6 results correlated strongly (r[ 0.72; P < .001) with
the actual measured walking ability (n [ 21).
Conclusions: VascuQoL-6 is a valid and responsive instrument for the assessment of health-related quality of life in PAD.
The main advantage is the compact format that offers a possibility for routine use in busy clinical settings. (J Vasc Surg
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://dx.doi.org/10.1016/j.jvs.2013.08.099The main goal of vascular surgical treatment efforts in
peripheral arterial disease (PAD) is limb salvage in critical
limb ischemia1 and improvement of walking ability in inter-
mittent claudication. Commonly used clinical tools for the
assessment of disease impact and results of invasive inter-
ventions in PAD include amputation-free survival, walking
performance during treadmill testing, patency of revascu-
larized arterial segments, and a variety of physiologic
measurements. However, these outcomes do not address
the PAD patient’s own perception about his or her actual
functional walking capacity, pain discomfort, or the social
and emotional implications of living with PAD.2
Therefore, it has been suggested that objective out-
come measures should be complemented with patient-
reported outcome measures.3,4 Such measures can
provide clinically useful additional decision-basis and
also important information about the results of different
medical interventions, with the potential to be integrated
in everyday clinical practice. In this context, most authors
recommend the use of disease-speciﬁc health-related
quality of life (HRQoL) instruments because they
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PAD patients,5 making them more sensitive to detect clin-
ically relevant changes in health status in response to
treatment.
The Vascular Quality of Life (VascuQoL) question-
naire, a PAD-speciﬁc HRQoL instrument, was develo-
ped by Morgan et al6 and ﬁrst published in 2001. The
VascuQoL questionnaire has been translated to several
languages,7 has been validated in the United Kingdom,8
and was ﬁrst used in the Bypass vs Angioplasty in Severe
Ischemia of the Leg (BASIL) trial.9 The instrument has
been recommended as the preferred questionnaire for
outcome measurement in patients with peripheral vascular
disease.5,8 The VascuQoL was also validated among
Swedish PAD patients by our research group.10 This
work was a necessary ﬁrst step to conﬁrm the validity of
the translated original VascuQoL instrument in a Swedish
context.
As with most HRQoL instruments, the VascuQoL
contains a relative abundance of items, making patient
completion of the instrument potentially too arduous and
time-consuming for routine use in busy clinics. A recent
review article looking at available measures for functional
and QoL status in intermittent claudication clearly links
brevity and ease of use in the clinical setting.2
In the last few decades, a system of national quality
registries has been established in the Swedish health and
medical services. These contain individualized data about
patient medical history, including medical and surgical
interventions and outcomes after treatment, for all health
care services.11 In this context, use of patient-reported
outcome measures is seen as essential, but the PAD-
speciﬁc HRQoL instruments currently available are too
cumbersome for robust and sustainable data collection.
The main aim of this study was therefore to develop
a short, yet efﬁcient, version of the VascuQoL for use in
everyday clinical practice among PAD patients.METHODS
This study was approved by the Regional Ethical
Review Boards at the University of Lund (No. 315/
2008) and Gothenburg (No. 501/2009).
Study population. The study recruited 200 consecu-
tive patients with an established diagnosis of PAD from
two academic vascular centers in Sweden. A senior vascular
surgeon established the diagnosis, and all patients were
considered as having symptoms of critical limb ischemia
(n ¼ 71) or claudication (n ¼ 129) attributable to periph-
eral vascular disease. All participants unaided completed
the Swedish VascuQoL questionnaire while being evalu-
ated for treatment in the outpatient clinic. In one of the
participating hospitals, 127 of the enrolled patients also
completed the questionnaire 6 months after a vascular
procedure. A subset of 21 patients also participated in an
outdoor test walk monitored by a global positioning system
(GPS). Prospectively deﬁned cardiovascular risk factors
were collected from the medical records.Solely for cognitive interviews, as described below,
15 more patients with moderate intermittent claudication
(Rutherford stage 3) were consecutively recruited from
the vascular surgical outpatient clinic at one of the two
participating centers.
The VascuQoL. The VascuQoL aims to assess QoL in
PAD regardless of disease severity (ie, in intermittent clau-
dication and in critical limb ischemia). The questionnaire
comprises 25 items, divided into ﬁve subscales (domains):
pain (4 items), symptoms (4 items), activities (8 items),
social (2 items), and emotional (7 items). Every item has
a 7-point response scale. When summarizing item res-
ponses, an overall score and ﬁve different domain scores are
generated, ranging from 1 (worst HRQoL) to 7 (best
HRQoL).
Psychometric item selection and reduction
strategy. For item selection and reduction from VascuQoL-
25 we applied the following criteria:
1. Correlation analysis criteria (item score vs total
score): choosing the items that correlate most
strongly with the total score of VascuQoL-25.
2. Exploratory factor analysis criteria: choosing the
items with the strongest factor loading in a single
factor model for all 25 variables.
3. Disease burden criteria: choosing the items where
respondents report most problems or limitations.
4. Responsiveness criteria: choosing items that change
most after treatment.
5. Content criteria: selecting at least one item from
every domain of VascuQoL-25.
After applying these criteria, we decided to choose one
item from every domain of VascuQoL, except for the
“activity” domain, from which two items were chosen,
because limitations in activities are a central consequence
of PAD. Two items (item 9 “During the past two weeks,
the distance I can walk has improved. . .” and item 24
“During the past two weeks, the distance I can walk
became less. . .”) were excluded because of suboptimal
item construction. We then tested the correlation (Pearson
correlation coefﬁcient) of the short instrument (Vascu-
QoL-6) vs VascuQoL-25, aiming for r $ 0.90.
For reliability assessment, we calculated the Cronbach
a for the short version. The Cronbach a measures internal
consistency, which refers to the extent to which the items
within a scale are inter-related. Cronbach a coefﬁcients >.7
are generally regarded as acceptable for psychometric scales,
although .9 is recommended for individual patient assess-
ment.12 We assessed sensitivity by exploring the capacity of
VascuQoL-6 to discriminate between patients with intermit-
tent claudication and critical limb ischemia by using nonpara-
metric statistical testing (Mann-Whitney U test).
Cognitive interviews. Fifteen patients (seven women
and eight men) with moderate-to-severe intermittent clau-
dication (Rutherford stage 3) were consecutively recruited
for cognitive interviews.13 The individual interviews took
place at the vascular surgical outpatient clinic and lasted
Table I. Demographics and risk factors in the patient
population
Variables
Mean 6 SD or
No. (%) (n ¼ 200)
Demographics





Regular smoking (current or in last
5 years)
97 (49)
Previous TIA or stroke 20 (10)
Diabetes 57 (29)
Hyperlipidemia 22 (11)
Angina pectoris/previous MI 85 (43)
Chronic pulmonary disease 25 (13)
Kidney diseasea 19 (10)
Ankle-brachial index 0.70 6 0.18
MI, Myocardial infarction; SD, standard deviation; TIA, transient ischemic
attack.
aDeﬁned as serum creatinine >150 mmol/L.
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of 69 years (range, 54-80 years). Every participant read the
original VascuQoL version and was asked the following
questions for all 25 items:
d Do you consider this question relevant in relation to
your disease?
d Do you think this question is comprehensible?
Every participant thoroughly read every question of the
instrument and was asked for additional comments and
suggestions for improving the questions and the response
options.
Rasch analysis. Rasch models14 analyze valuation data
about capabilities, attitudes, and personalities. The models
can give information about how well items function to
describe capability or personalities. The psychometric
qualities tested by the Rasch analysis are:
d Rating scale. This test explores the category thresh-
olds. VascuQol-25 has seven response options, which
mean that there are six thresholds between the
response options.
d Discrimination. This test explores how many levels of
person-ability that the questionnaire can discriminate.
The test results in two measures: person separation
and a separation reliability coefﬁcient. The latter is
a measure of precision.15 Precision is a fundamental
characteristic of a measurement instrument.
d Item ﬁt statistics. This test produces two measures:
inﬁt and outﬁt mean square. The test explores if each
item contributes to the respondent’s capability in
a predictable way. Both measures should have a value
of 1.0. Accepted limits are from 0.7 to 1.3.16
d Targeting. This test explores if the difﬁculty of the
items and the ability of the respondents have about
the same mean. There should be easy items for poorly
performing patients and difﬁcult items for the able
patients.17
d Unidimensionality. The items should measure the
same underlying trait and no other dimensions. If the
questionnaire does not fulﬁll this criterion, no
summary score can be calculated.18
d Differential item functioning. Differential item func-
tioning (DIF) means that a particular group of patients
responds otherwise to a speciﬁc item although the
same amounts of the latent trait are measured. A large
DIF may cause poor ﬁtting of data to the Rasch model.
In our analysis, we tested DIF between groups with
different age and sex.15
The standardized response mean, based on the calcu-
lated Rasch person scores, was used for responsiveness
testing and was calculated as the mean difference in score
after a vascular surgery procedure compared with baseline,
divided by the standard deviation of the difference. We
used the Cohen criteria19 for grouping the effect size
(small, 0.2-0.5; moderate, 0.5-0.8; large, >0.8). In ourstudy questionnaire, responses (six items) were arranged
into a Rasch measurement model. The aim was to create
a latent variable of disability caused by peripheral vascular
disease on a single linear scale. Our analysis used a polyto-
mous Andrich rating scale model with joint maximum-
likelihood estimation. The calculations were made by the
Winsteps 3.70.2 program (Chicago, Ill).
GPS-monitored outdoor test walk. As an additional
test of criterion validity of the proposed new instrument,
and as an adjunct to the criterion validity established by
the baseline correlation between the VascuQoL-25 and
VascuQoL-6 in 200 patients and the postintervention
correlation in 127 patients, a test of everyday walking
ability was performed in a subgroup of 21 patients (10
women, 11 men) with mild to moderate intermittent
claudication (Rutherford stage 2 and 3). Patients were
a mean age of 69 years (range, 55-80 years).
This test walk was situated in a ﬂat park area with no
disturbing motorized vehicles or trafﬁc lights. The patients
were instructed to walk for 40 minutes at their leisure
walking pace and to stop when required by their claudica-
tion pain. The test was performed individually and was
monitored by a research nurse. We used an iPhone4 (Apple
Corp, Cupertino, Calif) equipped with the Walkmeter
walking performance application (Abvio Inc, San Fran-
cisco, Calif),20 which uses GPS technology to continually
record walking time, location, distance, elevation, and
speed. Spearman rank correlation coefﬁcients were used
to correlate the results from the test walks to the partici-
pants’ individual total scores for VascuQoL-25 and the
proposed VascuQol-6 instrument.
RESULTS
Study population and missing data. In the studied
population, mean age was 70 6 9 years, and 57% were
Table II. Item selection for the six-item Vascular Quality of Life (VascuQoL-6) assessmenta
Item-total correlation analysis Exploratory factor analysis Disease burden Responsiveness
Pearson correlations (r)




presented. Results of a
single factor model
including all 25 items.c
Mean item score before
treatment. A lower mean value
indicates more health
problems/limitations (range 1-7).
Change in item score after
treatment. A larger mean
change indicates greater
improvement.
Activity 16 0.74 Activity 16 76 Activity 4 2.15 Activity 18 1.92
Social 6 0.72 Activity 22 76 Pain 1 2.20 Pain 1 1.91
Activity 22 0.71 Social 6 72 Activity 18 2.58 Emotional 12 1.91
Emotional 25 0.69 Activity 14 72 Emotional 12 2.69 Pain 20 1.76
Activity 14 0.69 Activity 18 71 Symptoms 5 2.74 Activity 4 1.74
Emotional 12 0.68 Social 15 71 Pain 20 2.79 Activity 10 1.60
Emotional 11 0.67 Emotional 12 70 Activity 10 3.10 Symptoms 5 1.59
Social 15 0.66 Emotional 11 70 Social 15 3.32 Symptoms 8 1.50
Pain 20 0.66 Emotional 25 69 Activity 14 3.33 Emotional 19 1.48
Symptoms 5 0.66 Pain 20 68 Activity 22 3.37 Pain 7 1.46
Activity 18 0.65 Symptoms 5 67 Symptoms 8 3.53 Social 15 1.40
Emotional 21 0.65 Emotional 19 67 Emotional 19 3.71 Activity 22 1.34
Emotional 19 0.65 Activity 10 65 Pain 7 3.93 Emotional 25 1.31
Pain 13 0.63 Emotional 21 65 Emotional 25 4.03 Symptoms 3 1.17
Pain 7 0.63 Symptoms 8 62 Symptoms 3 4.20 Activity 14 1.17
Symptoms 8 0.62 Pain 7 61 Activity 16 4.20 Activity 16 1.17
Activity 10 0.62 Activity 4 61 Pain 13 4.35 Emotional 11 1.03
Emotional 2 0.60 Pain 13 61 Emotional 11 4.37 Emotional 23 0.99
Emotional 23 0.60 Emotional 2 59 Social 6 4.58 Social 6 0.94
Activity 4 0.57 Emotional 23 58 Emotional 2 4.61 Pain 13 0.94
Pain 1 0.51 Pain 1 53 Emotional 21 4.92 Symptoms 17 0.93
Symptoms 17 0.49 Symptoms 17 48 Emotional 23 4.74 Emotional 2 0.83
Symptoms 3 0.42 Symptoms 3 41 Symptoms 17 5.21 Emotional 21 0.82
Activity 9d 0.16 Activity 9 24 Activity 9 1.73 Activity 9 1.60
Activity 24d 0.57 Activity 24 58 Activity 24 4.71 Activity 24 1.26
VascuQoL-25, 25-item Vascular Quality of Life.
aSummary of psychometric analysis of the VascuQoL-25 items according to four criteria: item-total correlation analysis, exploratory factor analysis, disease
burden and responsiveness. Items are labeled according to the health domain they represent in VasuQoL-25. Item numbers correspond to the placement in
VascuQoL-25.6 The six items selected for the VascuQoL-6 are in bold type.
bCorrected for overlap means that the value of the test item is subtracted from the total VascuQoL-25 score.
cOne factor accounted for 74.4% of the variance.
dItems 9 and 24 were excluded because of suboptimal item construction.
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smoking (previous or current), 29% had a diagnosis of dia-
betes, and 43% had coronary heart disease (Table I).
Missing data were negligible (0%-3%) for all items, because
183 of the 200 patients (92%) had complete VascuQoL
registrations, and every participant had a computable scale
(using the half-scale method). The mean time taken to
complete the VascuQoL-6 was signiﬁcantly less than that
of the VascuQoL-25 (1.4 vs 9.6 minutes; P < .001).
Psychometric item selection strategy. The results of
the psychometric analysis are summarized in Table II. The
item-total correlation analysis shows the strength of
association between each of the 25 VascuQoL items and
the total VascuQoL-25 score. Items with strong correla-
tion are regarded as the best indicators of the total
VascuQoL-25. Results of exploratory factor analysis
indicate which of the 25 items best represents the latent
variable, QoL in this case, in PAD patients. The outcome
of the item-total correlation analysis was similar to the
item-factor pattern obtained from factor analysis.
However, a somewhat different item structure was
uncovered when the disease burden and responsivenesscriteria were applied (Table II). The analysis of disease
burden pointed out which areas (items) the respondents
reported the most problems or limitations in QoL. The
evaluation of responsiveness indicated which items were
most sensitive to change in QoL after treatment. Our
intention was to select items that performed well
according to all selection criteria.
However, because the aim was to construct a short-
form instrument that would perform well for the descrip-
tion of disease severity and also as an outcome measure
after a vascular intervention, we attached greater impor-
tance to items that were most effective according to disease
burden and responsiveness criteria. Also, because walking
limitations are of great concern for most PAD patients,
we chose two items from the activity domain and one
item from the remaining four domains (symptoms, pain,
social, and emotional subscales), resulting in six items for
the short version of the instrument, VascuQoL-6
(Appendix, online only). The selection of two items from
the activity domain was supported by factor analysis, which
revealed that four of the ﬁve highest loading items were
from the activity domain (Table II).
Fig 1. Scatterplots show the correlation between the original 25-item Vascular Quality of Life (VascuQoL-25)
assessment and six-item version (VascuQoL-6) (left) before and (right) after vascular surgical intervention.
Fig 2. Category thresholds for item20 in the (A)original 25-itemVascularQuality of Life (VascuQol-25) assessment before
categories were collapsed and (B) for the same item in the six-item version (VascuQol-6) after categories were collapsed.
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VascuQoL-6 was r ¼ 0.88 before intervention, r ¼ 0.96
after intervention, and the difference was r ¼ 0.91 (P <
.001; Fig 1). Adding more items to VascuQoL-6 improved
the correlations only marginally. The Cronbach a for the
VascuQoL-6 was .85 before and .94 after intervention,
indicating good internal consistency. The VascuQoL-6
signiﬁcantly differentiated intermittent claudication
patients from critical limb ischemia patients (P < .001).
Cognitive interviews. Every item of VascuQoL-25
was considered comprehensible by the responders. Items
2, 11, 17, 21, and 23 were considered least relevant in
relation to the disease. Most responders (14 of 15) com-
mented on the abundance of response options, and sug-
gested that three to four response options should be used.Of the suggested items for the short version, the partici-
pants considered all of the selected items as highly relevant
for PAD disease.
Rasch analysis. Rasch analysis demonstrated disor-
dered category thresholds in the original VascuQol-25.
The categories for the six items were collapsed from 7
(VascuQoL-25) to 4 (VascuQoL-6), which gave ordered
thresholds (Fig. 2). Person separation for VascuQoL-6 was
2.23, and the separation reliability coefﬁcient was 0.83,
indicating high precision. Item ﬁt was good with “inﬁt”
between 0.85 and 1.23 and “outﬁt” between 0.79 and
1.12. Targeting showed that the degree of difﬁculty of the
items matched the ability of the responders (Fig 3). Item
mean was 0 logits, and person mean was 0.09 logits.
Evidence of unidimensionality was shown by residual
Fig 3. Person-item map for the six-item version of the Vascular
Quality of Life (VascuQol-6) assessment shows the ability of the
patients to the left and the difﬁculty of the items to the right of
a linear scale. The measure of the linear scale is logits, which is the
logarithm of the odds ratio for being able to perform an item
activity successfully. The distance between a respondent and an
item on the scale shows the probability of the respondent to
perform successfully the item activity. Ideally, person and item
mean should center on the same mean value. #, Persons;M, mean;
S, 1 standard deviation; T, 2 standard deviations; VASC 12F, item
12 from original VascuQol-25.
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measures was comparable for empirical calculation (62.7%)
and by the model (62.5%). The VascuQol-6 was free of DIF
(<0.5 logits) by sex and age. The standardized response
mean, calculated on the person scores achieved from Raschanalysis, was 1.15 for the short version, which indicates
excellent responsiveness.
For the ﬁnal selection of response options, we analyzed
the utilization frequencies of the different item response
options before and after vascular intervention. We chose
the response options that were most frequently used by
the responders, taking into account the need for equidis-
tance between the different response options.
GPS-monitored outdoor test walk. VascuQoL-25
and VascuQoL-6 both correlated strongly with the
measured total walking distance (km) during the test walk.
The Spearman rank correlation coefﬁcient was r ¼ 0.78
(P < .01) for VascuQoL-25 and r ¼ 0.72 (P < .01) for
VascuQoL-6 (Fig 4).
DISCUSSION
Our main clinically important ﬁnding is that the
VascuQoL-6, a short version of the PAD-speciﬁc HRQoL
instrument VascuQoL, seems to be a valid and responsive
instrument for the measurement of HRQoL in PAD.
Using structured psychometric testing, we were able to
select the most efﬁcient items from the original instrument
and demonstrated a strong correlation between the scores
from the original and the short version of the instrument.
Rasch analysis conﬁrmed the validity of the new instrument
(VascuQoL-6) by demonstrating a high precision, item ﬁt,
and targeting in the studied sample. Moreover, the Rasch
analysis conﬁrmed the unidimensionality (ie, the instru-
ment measures only one underlying latent trait) of the
instrument and showed no signs of DIF as a consequence
of age or sex. Cognitive interviews with a subgroup of
PAD patients conﬁrmed that the selected items were
considered relevant from the patient perspective.
The validity of a shortened instrument can be estab-
lished by showing close correlation with the original longer
version, and this premise was used in creating shorter
versions of the Medical Outcome Study Short-Form 36
Health Survey.21-23 We have established “criterion valid-
ity” of the VascuQol-6 showing excellent correlation with
the VascuQol-25 not only at baseline but also after inter-
vention. Moreover, further criterion validity was estab-
lished because VascuQoL-6 scores also adequately
reﬂected objective walking capacity during a GPS-
measured outdoor test walk that approached a real-life
scenario. This approach to assess community-based
outdoor walking limitations has previously been shown to
provide valid estimates of walking ability in PAD patients.24
The combination of traditional psychometric testing and
Rasch analysis, as used in this study, has been used for
the development of HRQoL instruments within other
areas of medicine.25
One crucial component of a measurement scale is the
number of response options. To differentiate between indi-
viduals with different disease severity and divergent func-
tional limitations, it seems rational to offer several
response options. At the same time, the responders have
to be able to ﬁrmly differentiate between the response
alternatives.26 In our data set, we found that a reduction
Fig 4. Scatterplots show the correlations between (left) the 25-item original Vascular Quality of Life (VascuQoL-25)
assessment and (right) the six-item version (VascuQoL-6) vs the total covered distance during the 40-minute test walk
as determined by a global positioning system (GPS) using the iPhone4 (Apple Corp, Cupertino, Calif) equipped with
the Walkmeter walking performance application (Abvio Inc, San Francisco, Calif).
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gory thresholds according to the Rasch analysis, and adding
more options gave disordered and random answer patterns.
Limitations of our study include that our calculations
are based on a theoretic model and we do not know how
the presence of the other items of the VascuQoL affect
our data regarding the selected items for the short version.
This highlights the need for further validation and testing
of the new instrument in a different patient sample. Also,
we included only individuals with intermittent claudication
for the cognitive interviews and cannot exclude that inter-
viewing patients with critical limb ischemia would have
given a somewhat different result.
CONCLUSIONS
We would stress the importance of integrating patient-
reported outcome measures in daily vascular practice.27
These assessments provide important and useful data about
the vascular patient, adding a decision-base when evalu-
ating different treatment regimens. Another possibility is
to use such measurements as assessment tools for case
selection to invasive treatment and in clinical follow-up
programs.2 In PAD, the rapid and continuous develop-
ments of medical management and minimally invasive
treatment options underscore the need for valid patient-
reported outcome measures.3 Patient-based outcome
measures are also consequently recommended in the
TransAtlantic Inter-Society Consensus (TASC) II docu-
ment (recommendation 13) for determining success of
treatment in intermittent claudication.28 However, to be
useful in busy routine clinical scenarios, the instruments
ought to contain only a limited number of items in order
to be easy and rapid to complete. Instruments like that
are generally uncommon and mostly generic in nature,
making their use as an outcome measure in PADproblematic because of the lack of focus on the PAD
patient’s speciﬁc limitations.5
HRQoL is often a difﬁcult concept to measure, and
ease of use for any instrument is vital if broader use in an
everyday clinical setting is to become a reality. The ideal
QoL instrument, in addition to being valid and reliable
(and responsive) should be brief, have high response and
completion rates, and be easy for health professionals to
administer, score, and analyze. We believe that the
VascuQoL-6 meets these ideals, and this has been the
driving force behind the development of the instrument.29
Potential use of VascuQoL-6 includes integration in clinical
routine, as a follow-up tool for outpatient programs, and
also as an assessment of results after vascular surgical inter-
ventions. Further testing and validation is now required,
and is already ongoing, as the VascuQoL-6 is being used
as a complementary outcome measure in all patients
entered into the National Swedish Vascular Registry.AUTHOR CONTRIBUTIONS
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The six-item Vascular Quality of Life (VascuQoL-6)
health-related quality of life (HRQoL) instrument
1. Because of the poor circulation in my legs, the range
of activities that I would have liked to do in the past
two weeks has been.
1. Severely limiteddmost activities not done
2. Very limited
3. Very slightly limited
4. Not limited at alldhave done all the activities that
I wanted to
2. During the past two weeks, my legs felt tired or
weak.
1. All of the time
2. Some of the time
3. A little of the time
4. None of the time
3. During the past two weeks, because of the poor circu-
lation in my legs, my ability to walk has been.
1. Totally limited, couldn’t walk at all
2. Very limited
3. A little limited
4. Not at all limited
4. During the past two weeks, I have been concerned
about having poor circulation in my legs.1. All of the time
2. Some of the time
3. A little of the time
4. None of the time
5. During the past two weeks, because of the poor
circulation in my legs, my ability to participate in
social activities has been.
1. Totally limited, couldn’t socialize at all
2. Very limited
3. A little limited
4. Not at all limited
6. During the past two weeks, when I have had pain in
the leg (or foot) it has given me.
1. A great deal of discomfort or distress
2. A moderate amount of discomfort or distress
3. Very little discomfort or distress
4. No discomfort or distress
Each question is scored 1-4. The total score is achieved
by summarizing the score on each question, resulting in
a score between 6 and 24. Higher value indicates better
health status.
If you wish to use the VascuQoL-6 instrument for any
clinical or research purpose, please ﬁrst contact Dr Mark
B.F. Morgan regarding permission for use, stating your
intended purpose. Contact details for Dr Morgan are:
mark.morgan@bopdhb.govt.nz.
